drugset / Trial / NCT01780337

Oxytocin Effects on Cardiac Electrophysiology

NCT01780337

Phase 0 Completed 12 enrolled William Whang
RandomizedParallel-groupDouble-blindTreatment

Summary

In this pilot study the investigators will perform a double-blind randomized trial of intranasal oxytocin on measures of cardiac refractoriness, among individuals who are undergoing clinically indicated catheter ablation procedures for paroxysmal atrial fibrillation. The investigators seek to enroll 20 patients for this study, for the purpose of estimating effect sizes for a larger future study.

Timeline

Start
2013-01
Primary completion
2016-05
Completion
2016-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 20 iu Intranasal